EMTORA BIOSCIENCES
Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug. The company developing a novel formulation of rapamycin, eRapa for use in preventing the onset and recurrence of cancer. It manufactures a drug to slow the aging process and its efficacy in treating age-related diseases. The eRapa is the only pharmaceutical agent to demonstrate significantly increased healthspan and lifespan in rodent models, and Science, Nature, and Time magazines proclaimed the discovery of a special formulation of rapamycin to extend one’s life and health span among the most significant and exciting scientific breakthroughs of 2009.
EMTORA BIOSCIENCES
Social Links:
Industry:
Biotechnology Health Care Life Science Manufacturing Pharmaceutical
Founded:
2012-01-01
Address:
San Antonio, Texas, United States
Country:
United States
Website Url:
http://www.emtorabio.com
Total Employee:
1+
Status:
Active
Contact:
(210) 381-2486
Total Funding:
23.83 M USD
Current Employees Featured
Founder
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Emtora Biosciences
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Emtora Biosciences
UT Horizon Fund
UT Horizon Fund investment in Convertible Note - Emtora Biosciences
UT Horizon Fund
UT Horizon Fund investment in Seed Round - Emtora Biosciences
Official Site Inspections
http://www.emtorabio.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Emtora Biosciences"
Emtora Biosciences
We are commercializing eRapaâ„¢, a novel, targeted formulation of rapamycin, to suppress the onset and recurrence of cancer. Our pipeline includes several early stage cancers or …See details»
About Us - Emtora Biosciences
Emtora Biosciences is a clinical stage life science company developing a novel formulation of rapamycin, eRapaâ„¢, for use in preventing the onset and recurrence of cancer. eRapaâ„¢ was …See details»
Emtora Biosciences Company Profile | Management and
Emtora Biosciences is a clinical stage biopharmaceutical company headquartered in San Antonio, Texas. The company holds the exclusive license to eRapa, an improved formulation of …See details»
Emtora Biosciences - LinkedIn
Emtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapaâ„¢, for use in preventing the onset and recurrence of cancer. A Phase 1b safety and …See details»
Pipeline - Emtora Biosciences
Emtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapaâ„¢, for use in preventing the onset and recurrence of cancer.See details»
Emtora Biosciences - Crunchbase Company Profile & Funding
Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug. View contacts for Emtora Biosciences to …See details»
Emtora Biosciences - Company Profile & Staff Directory - ContactOut
Emtora Biosciences is a life science company developing a novel formulation of rapamycin, eRapaâ„¢, for use in preventing the onset and recurrence of cancer. A Phase 1b safety and …See details»
Emtora Biosciences - Overview, News & Similar companies
Apr 26, 2024 · View Emtora Biosciences (www.emtorabio.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Emtora Biosciences Company Profile - Office Locations ... - Craft
Emtora Biosciences is a biopharmaceutical company which holds the license to eRapa, a targeted formulation of rapamycin investigated to prevent cancer and other age-related medical …See details»
Emtora Biosciences - VentureRadar
We focus on solutions to support development and production of small molecule pharmaceuticals and the potential for synthesizing nanoparticles for development of nanotechnology-based …See details»
Emtora Clinical Data to be Highlighted in Podium Presentation at ...
SAN ANTONIO, April 30, 2024 -- (BUSINESS WIRE)--Emtora Biosciences, Inc., a privately-held, San Antonio-based biotechnology company developing a novel reformulated version of a …See details»
Emtora Awarded $16.9M Grant from the Cancer Prevention
Aug 19, 2022 · Emtora Biosciences is a clinical stage biopharmaceutical company headquartered in San Antonio, Texas. The company is developing eRapa TM, an encapsulated formulation of …See details»
Emtora Clinical Data to be Highlighted in Podium Presentation at ...
Apr 30, 2024 · Emtora Biosciences, Inc., a privately-held, San Antonio-based biotechnology company developing a novel reformulated version of a previously-approved drug today …See details»
Technology - Emtora Biosciences
ERapaâ„¢ was developed to improve rapamycin's pharmacokinetics. It is a a proprietary, patented, micro-encapsulated formulation of rapamycin that protects the active ingredient from rapid, low …See details»
Emtora Clinical Data to be Highlighted in Podium Presentation at ...
Apr 30, 2024 · Emtora Biosciences is a clinical stage biopharmaceutical company headquartered in San Antonio, Texas. The company is developing eRapa TM, an encapsulated formulation of …See details»
Emtora Biosciences Awarded $3 Million CPRIT Grant to Study …
Aug 26, 2019 · SAN ANTONIO-- ( BUSINESS WIRE )-- Emtora Biosciences, a privately-held, clinical stage life science company announced today that it will receive a SEED Award grant …See details»
Emtora Awarded $16.9M Grant from the Cancer Prevention
Aug 19, 2022 · Emtora Biosciences is a clinical stage biopharmaceutical company headquartered in San Antonio, Texas. The company is developing eRapa TM, an encapsulated formulation of …See details»
News - Emtora Biosciences
August 19, 2022: Emtora Awarded $16.9M Grant from Cancer Prevention & Research Institute of TexasSee details»
Emtora Biosciences Presents Phase Ib Data in Low Grade Prostate …
Feb 4, 2020 · Emtora’s core technology incorporates submicron rapamycin particles into a pH-sensitive polymer, improving bioavailability and allowing for consistent and lower dosing than …See details»
Shannon Kingman Email & Phone Number - RocketReach
Get Shannon Kingman's email address (s*****@emtorabio.com) and phone number (210-265-....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for …See details»